NCT06122415 · RECRUITING
The Swedish BioFINDER - Memory Clinic Study
This Swedish study is testing whether new blood tests can replace spinal fluid tests for diagnosing memory and dementia conditions. Researchers are comparing several blood biomarkers against the current gold-standard cerebrospinal fluid analysis in 1,200 memory clinic patients. The phase is unspecified — this is an observational validation study, not a drug trial, and no experimental treatment is being given.
You may qualify if
- Under investigation for cognitive symptoms at the Memory clinic.
- Cerebrospinal fluid and blood sampling is planned to be done as part of clinical practice even if the patient is not taking part of this study.
You're excluded if
- Not undergoing CSF or blood sampling as part of clinical practice.
- Not undergoing cognitive testing as part of clinical practice.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-04-06